INNOCOR as VAD Therapy Optimization

INNOCOR as VAD Therapy Optimization - INNOCOR_LVAD_Projekt

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011608

Enrollment

Registered

2017-10-05

Start date

2018-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Group 1: Test-session 1 LVAD (left-ventricular-assist-device) no changing pumpspeed : 10 male and 10 female heart failure patients with LVAD therapy will perform 2 test sessions, one in rest and the o

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: LVAD, mental and physical capacity, 18-65 y

Exclusion criteria

Exclusion criteria: lung disease, orthopaedic disease and contra indications of ergometry

Design outcomes

Primary

Measure	Time frame
measurement cardiac output in the first session as baseline and as therapy efficiency before and after changing pumpspeed.	—

Secondary

Measure	Time frame
Measuring quality of life prior to the session as a baseline and 4 weeks after the session with the EQ-5D	—

Countries

Germany

Contacts

Public ContactEzin Deniz

Medizinische Hochschule Hannover, Abteilung HTTG, OE 6210

deniz.ezin@mh-hannover.de+4917615324290

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026